Skip to content

Elecsys Cortisol II 6687733160Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04015630940677), received between Aug 23, 2023 and Apr 23, 2025 — classified as 2 malfunctions.

The most frequently reported specific device problem is “High Test Results” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results2
  • Incorrect, Inadequate or Imprecise Result or Readings1
  • Non Reproducible Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 23, 2025High Test Results; Non Reproducible Results; High Test Results; Non Reproducible Results

    THE INITIAL REPORTER RECEIVED A QUESTIONABLE ELECSYS CORTISOL II AND ELECSYS ACTH TEST SYSTEM (ACTH) RESULT FROM ONE PATIENT SAMPLE TESTED ON THE COBAS 6000 E601 MODULE. THIS MEDWATCH IS FOR THE ELECSYS CORTISOL II ASSAY. PLEASE REFER TO THE MEDWATCH WITH A1. PATIENT IDENTIFIER (B)(6) FOR THE ELECSYS ACTH TEST SYSTEM (ACTH) ASSAY REPORT. THE INITIAL RESULT OF THE INITIAL PATIENT SAMPLE WAS 24.27 UG/DL (24.3 UG/DL). THE REPEAT RESULT OF THE INITIAL PATIENT SAMPLE WAS 23.73 UG/DL. THE RESULT OF A NEW PATIENT SAMPLE WAS 12.51 UG/DL (12.5 UG/DL). THE PHYSICIAN QUESTIONED THE INITIAL RESULT AS IT DID NOT MATCH THE PATIENT'S PREVIOUS RESULT, PROMPTING THE PATIENT'S SAMPLE TO BE RERUN. THE RESULT OF THE NEW PATIENT SAMPLE WAS DEEMED CORRECT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 21892558 ↗
  • MalfunctionAug 23, 2023Incorrect, Inadequate or Imprecise Result or Readings; High Test Results; Incorrect, Inadequate or Imprecise Result or Readings; High Test Results

    THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH ELECSYS CORTISOL II ON A COBAS E411 DISK ANALYZER. THE SAMPLE INITIALLY RESULTED IN A CORTISOL VALUE OF 7.93 UG/DL. THE DOCTOR QUESTIONED THE RESULT AND THE SAMPLE WAS REPEATED, RESULTING IN A VALUE OF 1.51 UG/DL. THE REPEAT VALUE WAS DEEMED CORRECT AND WAS EXPECTED FOR THE PATIENT. THE CUSTOMER RE-CENTRIFUGED THE SAMPLE AND LOCATED A SMALL CLOT IN IT. THE CLOT WAS REMOVED AND THE SAMPLE WAS REPEATED THREE ADDITIONAL TIMES, RESULTING IN CORTISOL VALUES OF 1.53 UG/DL, 2.25 UG/DL, AND 2.39 UG/DL.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17604100 ↗

Other FLUOROMETRIC, CORTISOL devices

All FLUOROMETRIC, CORTISOL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page